STO · BRAIN.ST
BrainCool AB (publ)
SEK 1.03-SEK 0.04 (-3.37%)
BrainCool AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.26% below the high.
Loading market information…
STO · NEOLA.ST · SEK
Stock price, earnings
Quote as of Oct 29, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Neola Medical AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Neola Medical AB (publ)’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Neola Medical AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Neola Medical AB (publ) specializes in developing advanced medical devices for the continuous pulmonary assessment of premature babies. At the core of its offerings is NEOLA, a sophisticated medical instrument critical for neonatal intensive care. This device facilitates ongoing lung function monitoring and generates immediate alerts for critical, life-threatening complications. It achieves this by accurately tracking changes in lung volume and oxygen gas concentration. The ultimate goal of NEOLA is to enhance intensive care and promote healthier outcomes for infants born preterm. The company, formerly known as GPX Medical AB, officially changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was established in 2016 and is headquartered in Lund, Sweden.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| SEK 0.00-100.0% vs estimate |
| Q3 2024 | Nov 6, 2024 | -SEK 0.03 | SEK 1.70M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 1.03-SEK 0.04 (-3.37%)
BrainCool AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.26% below the high.
SEK 8.34-SEK 0.08 (-0.95%)
Integrum AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 30.15% below the high.
SEK 13.00-SEK 2.85 (-17.98%)
Xbrane Biopharma AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 35.0% below the high.
SEK 12.65-SEK 0.40 (-3.07%)
SciBase Holding AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 76.57% below the high.
SEK 1.25SEK 0.00 (0.0%)
Iconovo AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 31.69% below the high.
SEK 8.00+SEK 0.12 (+1.52%)
Arcoma AB’s quoted price sits in the lower half of its reported 52-week range, 20.4% below the high.
SEK 0.44+SEK 0.01 (+1.86%)
Nosa Plugs AB’s quoted price sits in the lower half of its reported 52-week range, 40.33% below the high.
SEK 0.40-SEK 0.01 (-2.69%)
AcuCort AB’s quoted price sits in the lower half of its reported 52-week range, 58.11% below the high.
